Temporal mapping of transcripts in herpesvirus 6 variants.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 109607)

Published in J Virol on May 01, 1998

Authors

P Mirandola1, P Menegazzi, S Merighi, T Ravaioli, E Cassai, D Di Luca

Author Affiliations

1: Dipartimento di Medicina Sperimentale e Diagnostica, Università di Ferrara, Italy.

Articles citing this

Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol (1999) 2.42

Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev (2005) 2.24

Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol (1999) 1.76

U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A (1998) 1.39

Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33

Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev Med Virol (2003) 1.06

Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol (2002) 1.05

Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol (1999) 0.99

Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91

Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J Virol (2000) 0.91

Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes. J Virol (1999) 0.87

Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins. Nucleic Acids Res (2015) 0.84

Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J Virol (2000) 0.83

Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol (2001) 0.81

The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell. Virol J (2007) 0.79

Long-lasting CD3+ T-cell deficiency after cord blood stem cell transplantation in a human herpesvirus 6-infected child. J Clin Microbiol (2005) 0.79

Cell culture systems to study Human Herpesvirus 6A/B Chromosomal Integration. J Virol (2017) 0.77

Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS One (2013) 0.77

Articles cited by this

Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology (1995) 4.77

Isolation of human lymphotropic herpesviruses from Uganda. Lancet (1987) 3.26

UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol (1994) 2.69

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology (1991) 2.37

Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol (1990) 2.34

Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30

Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol (1989) 2.28

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16

Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol (1991) 2.05

Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med (1993) 2.01

Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet (1991) 1.84

Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology (1991) 1.83

Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A (1991) 1.79

Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood (1994) 1.74

Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Infect Dis (1990) 1.70

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med (1994) 1.59

Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet (1990) 1.53

Human herpesvirus 6 in AIDS. Immunol Today (1995) 1.39

Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J Virol (1994) 1.33

Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol (1991) 1.32

Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis (1993) 1.32

The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology (1990) 1.24

Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23

Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23

Human herpesvirus 6 infection in renal transplantation. Transplantation (1990) 1.16

Structure and transcription of an immediate-early region in the human herpesvirus 6 genome. J Virol (1994) 1.10

Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child (1992) 1.05

Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6. J Virol (1995) 1.04

Distribution of HHV-6 variants in human tissues. Infect Agents Dis (1996) 1.03

Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med (1996) 1.03

RNA analysis using miniprep RNA in reverse transcription PCR. Biotechniques (1994) 1.02

Analysis of interstrain variation in a putative immediate-early region of human herpesvirus 6 DNA and definition of variant-specific sequences. Virology (1994) 0.99

Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters. J Virol (1995) 0.92

Fatal disseminated infection with human herpesvirus-6. J Pediatr (1992) 0.91

In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. AIDS Res Hum Retroviruses (1994) 0.89

Bone marrow suppression by human herpesvirus-6: comparison of the A and B variants of the virus. Blood (1995) 0.81

Human herpesvirus-6 and bone marrow transplantation. Blood (1995) 0.80

Characterization of human herpesvirus 6 strains isolated from patients with exanthem subitum with or without cutaneous rash. J Infect Dis (1992) 0.78

Articles by these authors

Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol (1974) 16.33

Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B. J Virol (1977) 3.82

RNA synthesis in cells infected with herpes simplex virus. VII. Control of transcription and of transcript abundancies of unique and common sequences of herpes simplex virus 1 and 2. J Virol (1973) 3.32

Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med (1996) 3.27

A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue. Proc Natl Acad Sci U S A (1972) 2.45

Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology. Infect Immun (1976) 2.35

Plaque dissociation of herpes simplex viruses: biochemical and biological characters of the viral variants. Intervirology (1977) 2.23

Herpes simplex virus DNA isolation from infected cells with a novel procedure. Virology (1979) 1.44

U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A (1998) 1.39

A(3) adenosine receptor ligands: history and perspectives. Med Res Rev (2000) 1.35

Analysis of herpes simplex virus nucleoprotein complexes extracted from infected cells. J Virol (1980) 1.25

Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24

Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol (1995) 1.22

A(2A) adenosine receptors in human peripheral blood cells. Br J Pharmacol (2000) 1.21

Aseptic meningitis in association with herpes progenitalis. N Engl J Med (1971) 1.15

Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis. J Gen Virol (1986) 1.13

[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol (2000) 1.12

The heterogenous regions in herpes simplex virus 1 DNA. Microbiologica (1983) 1.11

Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis (1996) 1.11

Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. Osteoarthritis Cartilage (2007) 1.08

Isolation of human herpesvirus 7 from an infant with febrile syndrome. J Med Virol (1995) 1.05

Distribution of HHV-6 variants in human tissues. Infect Agents Dis (1996) 1.03

Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J Virol (2001) 1.02

Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer (1996) 1.02

Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J Virol (1990) 1.01

Human herpesvirus 6 (variant A) in Kaposi's sarcoma. Lancet (1993) 0.99

DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology (1995) 0.98

Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol (1995) 0.97

Calcium dependent activation of skeletal muscle Ca2+ release channel (ryanodine receptor) by calmodulin. Biochem Biophys Res Commun (1995) 0.97

Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochem J (1994) 0.96

Constitutive expression in human cells of herpes simplex virus type 1 glycoprotein B gene cloned in an episomal eukaryotic vector. Virology (1988) 0.95

Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J Infect Dis (1995) 0.95

Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. Br J Pharmacol (2001) 0.94

High incidence of ependymomas induced by BK virus, a human papovavirus: brief communication. J Natl Cancer Inst (1977) 0.94

Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer (1992) 0.91

Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs (2002) 0.91

Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors. Int J Cancer (1989) 0.91

Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation (1999) 0.91

Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation (2000) 0.90

Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region. Virus Res (1989) 0.90

Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. J Med Chem (2000) 0.89

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists. J Med Chem (1999) 0.89

Herpes simplex virus DNA synthesis in a partially purified soluble extract from infected cells. J Virol (1979) 0.89

Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler (2004) 0.88

Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development. Curr Med Chem (2010) 0.88

Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™. Eur J Clin Microbiol Infect Dis (2011) 0.87

Novel, nonconsensus cellular splicing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is specific for human herpesvirus 6. Virology (1999) 0.86

A study in calves of an immunologic relationship between herpes simplex virus and Bovid herpesvirus 2. Comp Immunol Microbiol Infect Dis (1981) 0.86

Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J Infect Dis (1998) 0.86

Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR. J Gen Virol (2001) 0.85

Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes. Osteoarthritis Cartilage (2008) 0.84

Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors. Cell Mol Life Sci (2005) 0.84

Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders. J Med Virol (1996) 0.84

Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two human genital tumors. Virology (1986) 0.84

Effect of isotopic label on buoyant density determinations of viral DNA in the preparative ultracentrifuge. J Virol (1973) 0.83

Cooperative DNA binding of the bovine papillomavirus E2 transcriptional activator is antagonized by truncated E2 polypeptides. J Virol (1993) 0.83

B cell clonality in gastric lymphoid tissues of patients with Sjögren's syndrome. Ann Rheum Dis (1996) 0.82

Calmodulin binding sites of the skeletal, cardiac, and brain ryanodine receptor Ca2+ channels: modulation by the catalytic subunit of cAMP-dependent protein kinase? Biochemistry (1995) 0.82

Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. Br J Pharmacol (1998) 0.82

A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comp Immunol Microbiol Infect Dis (2005) 0.82

Simultaneous Guillain-Barrè syndrome and active human herpesvirus 6 infection in the central nervous system. J Clin Virol (2007) 0.82

Bam HI characterization of 15 HSV-DNAs isolated from recrudescent lesions of three individuals. Microbiologica (1984) 0.81

Human herpesvirus DNA in prostate and semen from HIV-negative individuals in Italy. AIDS (1997) 0.81

Human herpesvirus 6 infects and replicates in aortic endothelium. J Clin Microbiol (2000) 0.81

Role of malignant hyperthermia domain in the regulation of Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem (1996) 0.81

CD4 cytopenia and occasional expansion of CD4+CD8+lymphocytes in Sjögren's syndrome. Clin Exp Rheumatol (1996) 0.81

Human herpesvirus-6 infections in infants admitted to hospital. J Med Virol (1993) 0.81

Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection. Vaccine (2000) 0.81

A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells. Mol Pharmacol (1995) 0.81

Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection. Tissue Antigens (2014) 0.80

Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors. Bioorg Med Chem Lett (2000) 0.80

Role of IFN gamma on TNF alpha, IL-1 beta and IL-6 release during HHV-6 infection. New Microbiol (1996) 0.80

Vulvar carcinomas: search for sequences homologous to human papillomavirus and herpes simplex virus DNA. Mod Pathol (1990) 0.80

Is vestibular papillomatosis associated with human papillomavirus? J Med Virol (1991) 0.80

Temporal mapping of transcripts in human herpesvirus-7. J Gen Virol (1999) 0.80

Chimeric BK virus DNA episomes in a papillary urothelial bladder carcinoma. Intervirology (1995) 0.79